Press C M, Lillehaug A
Department of Morphology, Genetics and Aquatic Biology, Norwegian College of Veterinary Medicine, Oslo.
Br Vet J. 1995 Jan-Feb;151(1):45-69. doi: 10.1016/s0007-1935(05)80064-8.
Disease control by vaccination is widely used in European salmonid aquaculture against vibriosis (Vibrio anguillarum), cold-water vibriosis (Vibrio salmonicida), yersiniosis or enteric redmouth disease (Yersinia ruckeri) and furunculosis (Aeromonas salmonicida subsp. salmonicida). The vaccines against the Vibrio spp. and Y. ruckeri have proven effective especially when administered by injection. Furunculosis vaccines have been less successful and have relied on combination with potent adjuvants to achieve acceptable protection. Application of modern molecular techniques to furunculosis research has delivered a crop of experimental vaccines that incorporate purified virulence factors and have shown increased protection during challenge. Gene technology has also been used to create a defined, nonreverting mutation in a strain of A. salmonicida, which has enhanced the feasibility of attenuated live vaccines. The development of experimental subunit vaccines against the viral infections and the continued advances in the field of immunostimulants, adjuvants and antigen carriers provide considerable promise for the future development of commercial vaccines for use in salmonid aquaculture.
在欧洲鲑鱼养殖中,通过接种疫苗来控制疾病被广泛应用于预防弧菌病(鳗弧菌)、冷水弧菌病(杀鲑弧菌)、耶尔森氏菌病或肠道红嘴病(鲁氏耶尔森氏菌)以及疖疮病(杀鲑气单胞菌杀鲑亚种)。针对弧菌属和鲁氏耶尔森氏菌的疫苗已被证明是有效的,尤其是通过注射方式接种时。疖疮病疫苗的效果则不太理想,一直依赖与强效佐剂联合使用来获得可接受的保护效果。将现代分子技术应用于疖疮病研究已产生了一批实验性疫苗,这些疫苗包含纯化的毒力因子,在攻毒试验中显示出增强的保护作用。基因技术也被用于在杀鲑气单胞菌菌株中产生一个明确的、不会回复突变的突变体,这提高了减毒活疫苗的可行性。针对病毒感染的实验性亚单位疫苗的开发以及免疫刺激剂、佐剂和抗原载体领域的持续进展,为鲑鱼养殖商业疫苗的未来发展提供了可观的前景。